Skip to main content
Top
Published in: Critical Care 6/2014

Open Access 01-12-2014 | Research

Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

Authors: Andrés Cárdenas, Elsa Solà, Ezequiel Rodríguez, Rogelio Barreto, Isabel Graupera, Marco Pavesi, Faouzi Saliba, Tania Mara Welzel, Javier Martinez-Gonzalez, Thierry Gustot, Mauro Bernardi, Vicente Arroyo, Pere Ginès

Published in: Critical Care | Issue 6/2014

Login to get access

Abstract

Introduction

Hyponatremia is a marker of poor prognosis in patients with cirrhosis. This analysis aimed to assess if hyponatremia also has prognostic value in patients with acute-on-chronic liver failure (ACLF), a syndrome characterized by acute decompensation of cirrhosis, organ failure(s) and high short-term mortality.

Methods

We performed an analysis of the Chronic Liver Failure Consortium CANONIC database in 1,341 consecutive patients admitted to 29 European centers with acute decompensation of cirrhosis (including ascites, gastrointestinal bleeding, hepatic encephalopathy, or bacterial infections, or any combination of these), both with and without associated ACLF (301 and 1,040 respectively).

Results

Of the 301 patients with ACLF, 24.3% had hyponatremia at inclusion compared to 12.3% of 1,040 patients without ACLF (P <0.001). Model for end-stage liver disease, Child-Pugh and chronic liver failure-SOFA scores were significantly higher in patients with ACLF and hyponatremia compared to those without hyponatremia. The presence of hyponatremia (at inclusion or during hospitalization) was a predictive factor of survival both in patients with and without ACLF. The presence of hyponatremia and ACLF was found to have an independent effect on 90-day survival after adjusting for the potential confounders. Hyponatremia in non-ACLF patients nearly doubled the risk (hazard ratio (HR) 1.81 (1.33 to 2.47)) of dying at 90 days. However, when considering patients with both factors (ACLF and hyponatremia) the relative risk of dying at 90 days was significantly higher (HR 6.85 (3.85 to 12.19) than for patients without both factors. Patients with hyponatremia and ACLF had a three-month transplant-free survival of only 35.8% compared to 58.7% in those with ACLF without hyponatremia (P <0.001).

Conclusions

The presence of hyponatremia is an independent predictive factor of survival in patients with ACLF. In cirrhosis, outcome of patients with ACLF is dependent on its association with hyponatremia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ginès P, Guevara M: Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008, 48: 1002-1010. 10.1002/hep.22418.CrossRef Ginès P, Guevara M: Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008, 48: 1002-1010. 10.1002/hep.22418.CrossRef
2.
go back to reference European Association for the Study of the Liver: EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010, 53: 397-417. 10.1016/j.jhep.2010.05.004.CrossRef European Association for the Study of the Liver: EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010, 53: 397-417. 10.1016/j.jhep.2010.05.004.CrossRef
3.
go back to reference Moore KP, Aithal GP: Guidelines on the management of ascites in cirrhosis. Gut. 2006, 55: vi1–12-10.1136/gut.2006.099580.CrossRef Moore KP, Aithal GP: Guidelines on the management of ascites in cirrhosis. Gut. 2006, 55: vi1–12-10.1136/gut.2006.099580.CrossRef
4.
go back to reference Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H, Galeras JA, Giménez MD, Santos J, Cirera I, Morillas RM, Coll S, Solà R: Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006, 4: 1385-1394. 10.1016/j.cgh.2006.08.007.CrossRef Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H, Galeras JA, Giménez MD, Santos J, Cirera I, Morillas RM, Coll S, Solà R: Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006, 4: 1385-1394. 10.1016/j.cgh.2006.08.007.CrossRef
5.
go back to reference Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA: Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004, 40: 802-810. 10.1002/hep.1840400409.CrossRef Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA: Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004, 40: 802-810. 10.1002/hep.1840400409.CrossRef
6.
go back to reference Biggins S, Rodriguez HJ, Bachetti P, Bass NM, Roberts JP, Terrault NA: Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005, 41: 32-39. 10.1002/hep.20517.CrossRef Biggins S, Rodriguez HJ, Bachetti P, Bass NM, Roberts JP, Terrault NA: Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005, 41: 32-39. 10.1002/hep.20517.CrossRef
7.
go back to reference Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las HD, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P: MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut. 2007, 56: 1283-1290. 10.1136/gut.2006.102764.CrossRef Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las HD, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P: MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut. 2007, 56: 1283-1290. 10.1136/gut.2006.102764.CrossRef
8.
go back to reference Londoño MC, Guevara M, Rimola A, Navasa M, Taurà P, Mas A, García-Valdecasas JC, Arroyo V, Ginès P: Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006, 130: 1135-1143. 10.1053/j.gastro.2006.02.017.CrossRef Londoño MC, Guevara M, Rimola A, Navasa M, Taurà P, Mas A, García-Valdecasas JC, Arroyo V, Ginès P: Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006, 130: 1135-1143. 10.1053/j.gastro.2006.02.017.CrossRef
9.
go back to reference Dawwas MF, Lewsey JD, Neuberger J, Gimson AE: The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl. 2007, 13: 1115-1124. 10.1002/lt.21154.CrossRef Dawwas MF, Lewsey JD, Neuberger J, Gimson AE: The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl. 2007, 13: 1115-1124. 10.1002/lt.21154.CrossRef
10.
go back to reference Hackworth WA, Heuman DM, Sanyal AJ, Fisher RA, Sterling RK, Luketic VA, Shiffman ML, Maluf DG, Cotterell AH, Posner MP, Stravitz RT: Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int. 2009, 29: 1071-1077. 10.1111/j.1478-3231.2009.01982.x.CrossRef Hackworth WA, Heuman DM, Sanyal AJ, Fisher RA, Sterling RK, Luketic VA, Shiffman ML, Maluf DG, Cotterell AH, Posner MP, Stravitz RT: Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int. 2009, 29: 1071-1077. 10.1111/j.1478-3231.2009.01982.x.CrossRef
11.
go back to reference Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, Arroyo V, Kamath PS: Acute-on-chronic liver failure. J Hepatol. 2012, 57: 1336-1348. 10.1016/j.jhep.2012.06.026.CrossRef Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, Arroyo V, Kamath PS: Acute-on-chronic liver failure. J Hepatol. 2012, 57: 1336-1348. 10.1016/j.jhep.2012.06.026.CrossRef
12.
go back to reference Jalan R, Yurdaydin C, Bajaj JS, Acharya SK, Arroyo V, Lin HC, Gines P, Kim WR, Kamath PS, World Gastroenterology Organization Working Party: Toward an improved definition of acute-on-chronic liver failure. Gastroenterology. 2014, 147: 4-10. 10.1053/j.gastro.2014.05.005.CrossRef Jalan R, Yurdaydin C, Bajaj JS, Acharya SK, Arroyo V, Lin HC, Gines P, Kim WR, Kamath PS, World Gastroenterology Organization Working Party: Toward an improved definition of acute-on-chronic liver failure. Gastroenterology. 2014, 147: 4-10. 10.1053/j.gastro.2014.05.005.CrossRef
13.
go back to reference Moreau R, Jalan R, Gines P, Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL-CLIF Consortium: Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013, 144: 1426-1437. 10.1053/j.gastro.2013.02.042.CrossRef Moreau R, Jalan R, Gines P, Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL-CLIF Consortium: Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013, 144: 1426-1437. 10.1053/j.gastro.2013.02.042.CrossRef
14.
go back to reference Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V, CANONIC study investigators of the EASL-CLIF Consortium: Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014, 61: 1038-1047. 10.1016/j.jhep.2014.06.012.CrossRef Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V, CANONIC study investigators of the EASL-CLIF Consortium: Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014, 61: 1038-1047. 10.1016/j.jhep.2014.06.012.CrossRef
15.
go back to reference Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM: Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008, 359: 1018-1026. 10.1056/NEJMoa0801209.CrossRef Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM: Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008, 359: 1018-1026. 10.1056/NEJMoa0801209.CrossRef
16.
go back to reference Porcel A, Díaz F, Rendón P, Macías M, Martín-Herrera L, Girón-González JA: Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002, 162: 323-328. 10.1001/archinte.162.3.323.CrossRef Porcel A, Díaz F, Rendón P, Macías M, Martín-Herrera L, Girón-González JA: Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002, 162: 323-328. 10.1001/archinte.162.3.323.CrossRef
17.
go back to reference Arroyo V, Rodés J, Gutiérrez-Lizárraga MA, Revert L: Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis. 1976, 21: 249-256. 10.1007/BF01095898.CrossRef Arroyo V, Rodés J, Gutiérrez-Lizárraga MA, Revert L: Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis. 1976, 21: 249-256. 10.1007/BF01095898.CrossRef
18.
go back to reference Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC: Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol. 1995, 23: 123-128. 10.1016/0168-8278(95)80325-4.CrossRef Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC: Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol. 1995, 23: 123-128. 10.1016/0168-8278(95)80325-4.CrossRef
19.
go back to reference Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F: Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000, 32: 605-610. 10.1016/S1590-8658(00)80844-0.CrossRef Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F: Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000, 32: 605-610. 10.1016/S1590-8658(00)80844-0.CrossRef
20.
go back to reference Angeli P, Wong F, Watson H, Gines P: Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006, 44: 1535-1542. 10.1002/hep.21412.CrossRef Angeli P, Wong F, Watson H, Gines P: Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006, 44: 1535-1542. 10.1002/hep.21412.CrossRef
21.
go back to reference Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T: Hyponatremia in Kawasaki disease. Pediatr Nephrol. 2006, 21: 778-781. 10.1007/s00467-006-0086-6.CrossRef Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T: Hyponatremia in Kawasaki disease. Pediatr Nephrol. 2006, 21: 778-781. 10.1007/s00467-006-0086-6.CrossRef
22.
go back to reference Eisenhut M: Changes in renal sodium transport during a systemic inflammatory response. Pediatr Nephrol. 2006, 21: 1487-1488. 10.1007/s00467-006-0199-y.CrossRef Eisenhut M: Changes in renal sodium transport during a systemic inflammatory response. Pediatr Nephrol. 2006, 21: 1487-1488. 10.1007/s00467-006-0199-y.CrossRef
23.
go back to reference Park SJ, Shin JI: Inflammation and hyponatremia: an underrecognized condition?. Korean J Pediatr. 2013, 56: 519-522. 10.3345/kjp.2013.56.12.519.CrossRef Park SJ, Shin JI: Inflammation and hyponatremia: an underrecognized condition?. Korean J Pediatr. 2013, 56: 519-522. 10.3345/kjp.2013.56.12.519.CrossRef
24.
go back to reference Swart RM, Hoorn EJ, Betjes MG, Zietse R: Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011, 118: 45-51. 10.1159/000322238.CrossRef Swart RM, Hoorn EJ, Betjes MG, Zietse R: Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011, 118: 45-51. 10.1159/000322238.CrossRef
Metadata
Title
Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study
Authors
Andrés Cárdenas
Elsa Solà
Ezequiel Rodríguez
Rogelio Barreto
Isabel Graupera
Marco Pavesi
Faouzi Saliba
Tania Mara Welzel
Javier Martinez-Gonzalez
Thierry Gustot
Mauro Bernardi
Vicente Arroyo
Pere Ginès
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0700-0

Other articles of this Issue 6/2014

Critical Care 6/2014 Go to the issue